会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • COATED PHARMACEUTICAL OR NUTRACEUTICAL PREPARATION WITH ACCELERATED CONTROLLED ACTIVE SUBSTANCE RELEASE
    • 加速控制的活性物质释放的包装药物或营养制剂
    • US20110070302A2
    • 2011-03-24
    • US12742263
    • 2008-02-01
    • Hema RAVISHANKARHans-Ulrich PETEREITShradda BODINGE
    • Hema RAVISHANKARHans-Ulrich PETEREITShradda BODINGE
    • A61K9/32A61K9/00A61K31/522A61P43/00
    • A61K9/5026A61K9/5078
    • The present invention relates to pharmaceutical or nutraceutical preparations comprising a) a core containing a pharmaceutically or nutraceutically active substance; and b) a controlling layer surrounding the core comprising i) 55 to 92% by weight based on the total weight of (meth)acrylic copolymers present in the layer of one or a mixture of a plurality of (meth)acrylate copolymers composed of 80 to 98% by weight based on the weight of the (meth)acrylic copolymer of structural units derived from C1 to C4 alkyl esters of (meth)acrylic acid and 2 to 20% by weight based on the weight of the (meth)acrylic copolymer of structural units derived from (meth)acrylate monomers with a quaternary ammonium group in the alkyl radical; and ii) 8 to 45% by weight based on the total weight of (meth)acrylic copolymers present in the layer of one or a mixture of a plurality of (meth)acrylate copolymers composed of more than 5 to 59% by weight based on the weight of the copolymer of structural units derived from acrylic acid or methacrylic acid, and to tablets and capsules containing same.
    • 本发明涉及药物或营养制剂,其包含a)含有药学或营养物质活性物质的核心; 和b)围绕芯的控制层,其包含i)55至92重量%,基于存在于由80重量份组成的多个(甲基)丙烯酸酯共聚物的一种或多种混合物的层中的(甲基)丙烯酸共聚物的总重量 至(甲基)丙烯酸共聚物的重量比为基于(甲基)丙烯酸的C1至C4烷基酯的结构单元的(甲基)丙烯酸共聚物的重量计为98重量%,以及(甲基)丙烯酸共聚物的重量为2至20重量% 衍生自烷基中具有季铵基团的(甲基)丙烯酸酯单体的结构单元; 和ii)8至45重量%,基于存在于由多于5至59重量%组成的(甲基)丙烯酸酯共聚物的一种或多种的(甲基)丙烯酸酯共聚物的层中的(甲基)丙烯酸共聚物的总重量) 衍生自丙烯酸或甲基丙烯酸的结构单元的共聚物的重量,以及含有它们的片剂和胶囊的重量。